Zusammenfassung
Die akute unkomplizierte Zystitis und die akute unkomplizierte Pyelonephritis stellen zwei häufige Harnweginfektionen (HWI) bei prämenopausalen, ansonsten gesunden Frauen dar. Neuere Untersuchungen belegen, dass die Inzidenz dieser Infektionen höher als erwartet ist. Umfragen zu Gesundheitspraktiken in Nordamerika zeigten eine hohe Variabilität in der Therapie von unkomplizierten HWI. Standardisierte Kriterien für die Diagnose und Therapie unkomplizierter HWI sind deshalb wichtig, um eine ausreichende Sensitivität und Spezifität im klinischen Alltag zu erreichen. Die „Infectious Diseases Society of America“ (IDSA) entwickelte evidenzbasierte Leitlinien für die antibiotische Behandlung von akuter unkomplizierter Zystitis und akuter unkomplizierter Pyelonephritis, die von anderen Expertengremien mit der aktuellen Studienlage abgeglichen wurden.
Abstract
Acute uncomplicated cystitis and acute uncomplicated pyelonephritis are two frequently encountered urinary tract infections (UTI) in premenopausal, healthy females. Recent epidemiological investigations showed that the incidence of these infections is higher than expected. Surveys on healthcare practices in North America revealed a high variability in the therapy of uncomplicated UTI. Standardized criteria for diagnosis and therapy of uncomplicated UTIs therefore are important in order to achieve sufficient sensitivity and specificity in clinical practice. The Infectious Diseases Society of America (IDSA) developed evidence-based guidelines for the treatment of acute uncomplicated cystitis and acute uncomplicated pyelonephritis, which were recently updated by other expert groups.
Literatur
Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ (2004) The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis 36(4): 296–301
Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM (2002) Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 52(482): 729–734
Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22 [Suppl 2]: 49–52
Kahlmeter G (2003) An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51(1): 69–76
Naber KG (1999) Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol 9(1): 57–64
Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29(4): 745–758
Goettsch WG, Janknegt R, Herings RM (2004) Increased treatment failure after 3-days‘ courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 58(2): 184–189
Raz R, Chazan B, Kennes Y et al. (2002) Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 34(9): 1165–1169
Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD (1998) A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 10(1): 39–47
Henning C, Bengtsson L (1997) Treatment of acute urinary disorders. Simple tests and questions make the diagnosis and therapeutic choices easier. Lakartidningen 94(25): 2387–2390
Petersen EE, Wingen F, Fairchild KL et al. (1990) Single dose pefloxacin compared with multiple dose co-trimoxazole in cystitis. J Antimicrob Chemother 26 [Suppl B]: 147–152
Jardin A, Cesana M (1995) Randomized, double-blind comparison of single-dose regimens of rufloxacin and pefloxacin for acute uncomplicated cystitis in women. French Multicenter Urinary Tract Infection-Rufloxacin Group. Antimicrob Agents Chemother 39(1): 215–220
Del Rio G, Dalet F, Aguilar L, Caffaratti J, Dal-Re R (1996) Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations. Antimicrob Agents Chemother 40(2): 408–412
Henry DC Jr, Bettis RB, Riffer E et al. (2002) Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 24(12): 2088–2104
Nicolle LE, Madsen KS, Debeeck GO et al. (2002) Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 34(7): 487–492
Nicolle LE (2000) Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 46 [Suppl 1]: 35–65
Kahlmeter G, Menday P (2003) Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 52(1): 128–131
Kavatha D, Giamarellou H, Alexiou Z et al. (2003) Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrob Agents Chemother 47(3): 897–900
Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE (2005) Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 293(8): 949–955
Lecomte F, Allaert FA (1996) Le traitement monodose de la cystite par fosfomycin trometamol. Analyse de 15 essais comparatifs portant sur 2048 malades. Méd Malad Infect 26: 338–343
Schito GC (2003) Why fosfomycin trometamol as first line therapy for uncomplicated UTI? Int J Antimicrob Agents 22 [Suppl 2]: 79–83
Guay DR (2001) An update on the role of nitrofurans in the management of urinary tract infections. Drugs 61(3): 353–364
Cunha BA (2001) Antibiotic side effects. Med Clin North Am 85(1): 149–185
Brumfitt W, Hamilton-Miller JM (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years‘ experience. J Antimicrob Chemother 42(3): 363–371
Karpman E, Kurzrock EA (2004) Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol 172(2): 448–453
Iravani A, Tice AD, McCarty J et al. (1995) Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group. Arch Intern Med 155(5): 485–494
Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselin L, Rochette L (2004) Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 170(4): 469–473
Backhouse CI, Matthews JA (1989) Single-dose enoxacin compared with 3-day treatment for urinary tract infection. Antimicrob Agents Chemother 33(6): 877–880
Iravani A (1993) Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 94(3A): 89–96
Iravani A CP, Maladorno D (1995) Fleroxacin in the treatment of uncomplicated urinary tract infections in women. 7th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 1995 March 26–30, Vienna, Austria
Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY (2002) Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 59(3): 334–339
Naber KG, Allin DM, Clarysse L et al. (2004) Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Int J Antimicrob Agents 23(6): 596–605
Richard GA, Klimberg IN, Fowler CL, Callery-D’Amico S, Kim SS (1998) Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 52(1): 51–55
Neringer R, Forsgren A, Hansson C, Ode B (1992) Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Scand J Infect Dis 24(6): 773–780
Nicolle LE, DuBois J, Martel AY, Harding GK, Shafran SD, Conly JM (1993) Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother 37(3): 574–579
Spencer RC, Moseley DJ, Greensmith MJ (1994) Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother 33 [Suppl A]: 121–129
The Inter-Nordic Urinary Tract Infection Study Group (1988) Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. Scand J Infect Dis 20(6): 619–624
Piipo TPT, Salo SA (1990) Three-day versus seven-day treatment with norfloxacin in acute cystitis. Curr Ther Res 47: 644–653
Block JM, Walstad RA, Bjertnaes A et al. (1987) Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs 34 [Suppl 1]: 100–106
Hooton TM, Latham RH, Wong ES, Johnson C, Roberts PL, Stamm WE (1989) Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother 33(8): 1308–1312
Hooton TM, Johnson C, Winter C et al. (1991) Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother 35(7): 1479–1483
Naber KG BW, Fischer M, Kresken M (1994) Pefloxacin single-dose in the treatment of acute uncomplicated lower urinary tract infections in women: a meta-analysis of seven clinical trials. Int J Antimicrob Agents 4: 197–202
Menday AP (2002) Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection. Int J Antimicrob Agents 20(4): 297–300
Gossius GVL (1985) The treatment of acute dysuria-frequency syndrome in adult women: double-blind, randomized comparison of three-day vs. ten-day trimethoprim therapy. Curr Ther Res 37: 34–42
Kunin C (1997) Detection, prevention and management of UTIs, 5th edn. Lea & Febiger, Philadelphia
Kass E (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Phys 69: 56–64
Hamm M, Wawroschek F, Weckermann D et al. (2001) Unenhanced helical computed tomography in the evaluation of acute flank pain. Eur Urol 39(4): 460–465
Stamm WE, McKevitt M, Counts GW (1987) Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial. Ann Intern Med 106(3): 341–345
Talan DA, Stamm WE, Hooton TM et al. (2000) Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 283(12): 1583–1590
Talan DA, Klimberg IW, Nicolle LE, Song J, Kowalsky SF, Church DA (2004) Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 171(1): 734–739
Naber KG, Bartnicki A, Bischoff W et al. (2004) Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 23 [Suppl 1]: 41–53
Naber KG, Hauke W (2001) Cefpodoxime proxetil in patients with acute uncomplicated pyelonephritis. International, prospective, randomized comparative study versus ciprofloxacin in general practice. Chemother J 10: 29–34
Finkelstein R, Kassis E, Reinhertz G, Gorenstein S, Herman P (1998) Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect 38(3): 193–202
Nicolle LE (1999) Pivmecillinam for the treatment of acute uncomplicated urinary infection. Int J Clin Pract 53(8): 612–617
Bailey RR (1994) Single-dose/short-term therapy in children and in pregnant women. Infection 22 [Suppl 1]: 47–48
Krcmery S, Hromec J, Demesova D (2001) Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 17(4): 279–282
Gilstrap LC 3rd, Cunningham FG, Whalley PJ (1981) Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 57(4): 409–413
Anonymus (2005) Antimicrobials in pregnancy. FDA pregnancy categories. Anonymus
Kämmerer WME (2002) Pharmaka und Schwangerschaft – Eine Übersicht. In: Freise KMF (ed) Arzneimitteltherapie in der Frauenheilkunde. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Kass EH (1960) Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 105: 194–198
Gratacos E, Torres PJ, Vila J, Alonso PL, Cararach V (1994) Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Inf Dis 169: 1390–1392
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of Nephrology, American Geriatric Society (2005) Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40: 643–654
Bailey RR (1994) Single-dose/short-term therapy in children and in pregnant women. Infection 22 [Suppl 1]: 47–48
Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A (2000) Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev CD000491
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagenlehner, F.M.E., Hoyme, U. & Naber, K.G. Therapie der akuten unkomplizierten Harnweginfektion. Urologe 45, 429–435 (2006). https://doi.org/10.1007/s00120-006-1022-x
Issue Date:
DOI: https://doi.org/10.1007/s00120-006-1022-x